Recombinant parathyroid hormone (1-34) - Uni-Bio Science Group
Alternative Names: Recombinant parathyroid hormone (1-34); Uni PH (1-34); Uni rPH (1-34); Uni-PTHLatest Information Update: 12 Oct 2021
Price :
$50 *
At a glance
- Originator Uni-Bio Science Group
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Postmenopausal osteoporosis
Most Recent Events
- 12 Oct 2021 Registered for Postmenopausal osteoporosis in China, Prior to October 2021 (SC) (Uni-Bio Science Group pipeline, October 2021)
- 04 Sep 2021 National Medical Products Administration approves IND application for Uni-PTH (pre-filled injection pen) in Osteoporosis and Pain in China
- 05 May 2020 Uni-Bio Science Group entered in to strategic parternship with Ypsomed to develop 2nd Generation Uni-PTH alongside YpsoPen® in Osteoporosis and Pain in bone